Acrizanib, also known as LHA510, is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
MedKoo Cat#: 126210
Name: Acrizanib hydrochloride
CAS#: 1637434-72-0 (HCl)
Chemical Formula: C20H19ClF3N7O2
Exact Mass: 481.1241
Molecular Weight: 481.86
Elemental Analysis: C, 49.85; H, 3.97; Cl, 7.36; F, 11.83; N, 20.35; O, 6.64
The following data is based on the product molecular weight 481.86 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
